CAPTRUST Financial Advisors
BLUE

CAPTRUST Financial Advisors’s bluebird bio BLUE Stock Holding History

CAPTRUST Financial Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-500
Closed -$30 – 2679
2023
Q3 		$30 Buy
+500
New +$35.1K ﹤0.01% 2611

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

CAPTRUST Financial Advisors's BLUE Position: Q4 2024 in Review

CAPTRUST Financial Advisors sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 11,882 shares — an estimated $123K sold.

CAPTRUST Financial Advisors first reported a position in BLUE in Q2 2018 and held it in 21 quarters. The position peaked at $795K in Q3 2020. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • CAPTRUST Financial Advisors reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 11,882 bluebird bio shares in Q4 2024, an estimated $123K.
  • CAPTRUST Financial Advisors first reported a position in bluebird bio in Q2 2018 and held it in 21 quarters.
  • CAPTRUST Financial Advisors's bluebird bio position peaked at $795K in Q3 2020.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.